Page last updated: 2024-08-25

5-fluoropyrimidine and Lymph Node Metastasis

5-fluoropyrimidine has been researched along with Lymph Node Metastasis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duan, J; Jiang, Y; Liao, W; Lin, L; Pan, C; Su, Y; Sun, L; Zhang, J1
Araki, K; Dabanaka, K; Hanazaki, K; Hokimoto, N; Kobayashi, M; Maeda, H; Munekage, M; Namikawa, T; Okabayashi, T; Sugimoto, T1

Other Studies

2 other study(ies) available for 5-fluoropyrimidine and Lymph Node Metastasis

ArticleYear
Low expression of DLC1 is predictive of poor therapeutic efficiency of fluoropyrimidine and oxaliplatin as adjuvant chemotherapy in gastric cancer.
    Molecular medicine reports, 2015, Volume: 12, Issue:4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemotherapy, Adjuvant; Female; Gene Expression Regulation, Neoplastic; GTPase-Activating Proteins; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Prognosis; Pyrimidines; Retrospective Studies; Signal Transduction; Stomach Neoplasms; Survival Analysis; Tumor Burden; Tumor Suppressor Proteins

2015
A case with synchronous multiple liver metastases from gastric carcinoma: postoperative long-term disease-free survival.
    Langenbeck's archives of surgery, 2009, Volume: 394, Issue:4

    Topics: Adenocarcinoma; Disease-Free Survival; Gastrectomy; Hepatectomy; Humans; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Prognosis; Pyrimidines; Stomach Neoplasms; Time Factors

2009